The Human Proteome Organization (HUPO) 2011 World Congress, Geneva, Switzerland, recently recognized the work of four scientists for their contributions to advancement in proteomics.
The Human Proteome Organization (HUPO) 2011 World Congress, Geneva, Switzerland, recently recognized the work of four scientists for their contributions to advancement in proteomics. Honored at the awards ceremony, which took place on September 7, were Amos Bairoch, Steve Carr, He Fuchu, and Alexander Makarov.
Bairoch, director of the Structural Biology and Bioinformatics Department at the University of Geneva, and group leader at the Swiss Institute of Bioinformatics, Lausanne, Switzerland, received the HUPO distinguished Achievement Award in Proteomic Sciences.
Carr, director of proteomics at the Broad Institute of the Massachusetts Institute of Technology, and Harvard University, both in Cambridge, Massachusetts, received the HUPO Discovery Award in Proteomics Sciences.
Fuchu, academician of the Chinese Academy of Sciences and director of the National Biomedical Analysis Center, both in Beijing, China, received the HUPO Distinguished Service Award.
Makarov, director of global research for life sciences mass spectrometry at Thermo Fisher Scientific, Bremen, Germany, received the first HUPO Science and Technology Award.
Get essential updates on the latest spectroscopy technologies, regulatory standards, and best practices—subscribe today to Spectroscopy.
AI-Powered Raman with CARS Offers Laser Imaging for Rapid Cervical Cancer Diagnosis
July 15th 2025Chinese researchers have developed a cutting-edge cervical cancer diagnostic model that combines spontaneous Raman spectroscopy, CARS imaging, and artificial intelligence to achieve 100% accuracy in distinguishing healthy and cancerous tissue.
How Analytical Chemists Are Navigating DOGE-Driven Funding Cuts
July 14th 2025DOGE-related federal funding cuts have sharply reduced salaries, lab budgets, and graduate support in academia. Researchers view the politically driven shifts in priorities as part of recurring systemic issues in U.S. science funding during administrative transitions. The impact on Federal laboratories has varied, with some seeing immediate effects and others experiencing more gradual effects. In general, there is rising uncertainty over future appropriations. Sustainable recovery may require structural reforms, leaner administration, and stronger industry-academia collaboration. New commentary underscores similar challenges, noting scaled-back graduate admissions, spending freezes, and a pervasive sense of overwhelming stress among faculty, students, and staff. This article addresses these issues for the analytical chemistry community.